Breast Cancer: Medication to Reduce Risk

An Update for This Topic is In Progress

LAST UPDATED: Mar 14, 2024

The Task Force keeps recommendations as current as possible by routinely updating existing recommendations and developing new recommendations. A multistep process is followed for each recommendation. The Task Force uses gold standard methods to review the evidence and is transparent at each step of the recommendation development process.

Public Comments are Closed for this topic.

See Current Final Recommendation Statement for Breast Cancer: Medication Use to Reduce Risk(2019)

Final Research Plan

The Recommendation Development Process

The Task Force follows a multistep process when developing each of its recommendations. Use the graphic below to see where this recommendation is in the development process. Learn about our full development process.

Opportunity for Comment
Draft Research Plan
 
Final Research Plan
 
Opportunity for Comment
Draft Recommendation
Draft Evidence Review
 
Final Recommendation
Evidence Summary